Return to Trial Database

HCRN-BRE89-1

Carboplatin and WR-2721 as First-Line Chemotherapy for Metastatic Breast Cancer (MBC): A Hoosier Oncology Group Study BRE89-1

Status

Study Completed

Cancer Type(s)

Study Contact

Publications

Carboplatin and WR-2721 as First-Line Chemotherapy for Metastatic Breast Cancer (MBC)

Trial Locations

All sites in which the trial HCRN-BRE89-1 being conducted in.

No data was found